Everly Bio

Everly Bio
Computational biology platform for optimizing IVF success rates and reducing treatment burdens.
About
What does Everly Bio do?
Everly Bio leverages biological and Omics computational datasets to empower IVF clinics, fertility specialists, and couples. Their technology aims to facilitate informed decision-making, maximize success rates, and minimize the emotional and financial toll associated with infertility treatments.
What is Everly Bio's revenue?
StartupHub estimates Everly Bio's annual revenue at $845K (range $476K to $1.3M, 64% confidence), based on comparable companies in the sector.
Where is Everly Bio headquartered?
Everly Bio is headquartered in San Francisco, United States.
When was Everly Bio founded?
Everly Bio was founded in 2017.
What industry does Everly Bio operate in?
Everly Bio operates in Life Sciences, Computational Biology, HealthTech, MedTech, Biotech, Genomics.
How many employees does Everly Bio have?
Everly Bio has approximately 5 people on record.
What is Everly Bio's current status?
Everly Bio's current operating status is: Inactive.
No comments yet. Be the first to share your take.